ARI2h-TM28ARI0002hnon-Hodgkin's lymphomalymphoblastic leukemiamultiple myelomaCART19
…val in relapse models with antigen downregulation. Furthermore, ARI2h-TM28 showed an optimized metabolic profile, more oxidative and energ…
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ARI0002h ×
ARI0002h
This drug is selected. Its supporting articles are shown below.